U.S.-based biotech stocks are closely watching the China's rapid advance into the biotech field. Will they withstand the ...

Biotech stock Anaptysbio cleared a trendline entry near 50 on Monday. Shares are also in a base with a buy point of 52.47.

And biotech stocks bounced back too. It felt like people were putting more value on the chance that a bigger company might ...